Viratech Corp. Launches Cancer.im Cancer Patient Support Social Network
STOCKTON, CA -- (Marketwire) -- 02/19/13 -- Viratech Corp.
(PINKSHEETS: VIRA), the first open source biotech research social
network platform, announced today the launch of Cancer.im,
http://cancer.im, a social network resource site for cancer patients,
survivors, advocates, and volunteers. Cancer.im harnesses social
collaboration utilities to develop what Viratech believes will become
the first experience-based search engine powered by social
Cancer.im, a wholly owned subsidiary of Viratech Corp., is being
hailed by journalists as "Facebook for Cancer Patients" and for good
reason. In fact, the site has many of the features of social
networking sites such as Facebook and LinkedIn, as well as Internet
health resources, like HealthStream. But Cancer.im goes one step
further. It is the first social network which has reversed engineered
an evidence based medicine study which has shown that by increasing
the quality of life of a cancer patient you can directly lower the
incidence of morbidity regardless of treatment.
Cancer.im is positioning itself to have the first mover advantage by
becoming the primary resource on the Web that people affected by
cancer will turn to in order to make a difference in their own lives
and the lives of others. Members can use Cancer.im to:
-- Create and mobilize their own Patient Support Network;
-- Learn from the wisdom of cancer survivors;
-- Research all aspects of cancer;
-- Organize their medical records, insurance, and research;
-- Create a customized strategy based on their educated beliefs, values
-- Create a proactive cancer prevention strategy.
Cancer.im was founded by people who have firsthand experience with
cancer. The network continues to grow thanks to individuals who
continually donate their time, resources and experience to help
cancer patients navigate the obstacles they face. Our driving
principles to create an internet-based support system are based on
clinical data which has shown that cancer patients who have an active
support network live longer than cancer pati
ents who do not and
increasing a cancer patient's quality of life directly lowers the
incidence of morbidity.
"We believe that the Cancer.im social network has the potential of
changing the way in which patients view and manage their disease,
thus allowing them to take back control and be more proactive in
their treatment decisions," states Dr. Kevin Buckman, CEO of Viratech
Cancer.im is also seeking new cancer researchers who wish to leverage
its intellectual property and social network platform for the purpose
of creating new distribution and engagement channels. Its first book,
Find and Stop Breast Cancer, by Kevin Buckman, MD has hit the best
seller list on Amazon.com for breast cancer.
Through its experience-based search engine and next-generation
technology, Cancer.im's goal is to become the primary resource on the
web for people affected by cancer, for the purpose of making a
difference in their own lives and the lives of others.
About Viratech Corp.
Viratech Corp. has created the first open
source biotech research social network platform. The purpose of the
platform is to make it possible for individuals or smaller companies
to compete with larger companies in the race to patent new medicines
or technology. This has been made possible by leveraging social
collaboration in a way that allows new biotech ventures the ability
to protect their intellectual property, then simultaneously allowing
those same ventures the ability to promote and crowdsource their
Kevin Buckman MD
Email Contact: firstname.lastname@example.org
Press spacebar to pause and continue. Press esc to stop.